Published in Cancer Res on August 15, 1989
Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med (1998) 1.89
Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer (1993) 1.34
Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. Biochem J (2003) 1.14
Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer (1991) 1.05
A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis (2013) 0.94
Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent. PLoS One (2012) 0.89
Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles. J Biol Inorg Chem (2005) 0.86
Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor. Br J Cancer (1997) 0.85
Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells. Br J Cancer (1993) 0.84
Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP. Cytotechnology (1998) 0.80
Intracellular distribution of anthracyclines in drug resistant cells. Cytotechnology (1998) 0.79
Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression. Vasc Cell (2014) 0.78
Reduced Intracellular Drug Accumulation in Drug-Resistant Leukemia Cells is Not Only Solely Due to MDR-Mediated Efflux but also to Decreased Uptake. Front Oncol (2014) 0.78
Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells. Br J Cancer (1999) 0.77
The Function of V-ATPases in Cancer. Physiol Rev (2016) 0.76
Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells. BMC Cancer (2016) 0.75
Mitochondrial localization of P-glycoprotein and peptide transporters in corneal epithelial cells--novel strategies for intracellular drug targeting. Exp Eye Res (2012) 0.75
Visualisation of doxorubicin in human and animal tissues and in cell cultures by immunogold-silver staining. Br J Cancer (1992) 0.75
An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL. Blood (2016) 0.75
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (1997) 16.09
Artemisinins target the SERCA of Plasmodium falciparum. Nature (2003) 7.72
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J (2001) 5.29
Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol (1993) 4.98
The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother (1999) 4.64
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet (2002) 4.47
Expression of the CD34 gene in vascular endothelial cells. Blood (1990) 4.41
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther (1998) 3.57
Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg (2001) 3.44
Albumin phylogeny for clawed frogs (Xenopus). Science (1977) 3.12
HIV-1 suppression during acute scrub-typhus infection. Lancet (2000) 3.08
Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med (1983) 3.07
Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum. J Infect Dis (1996) 2.59
Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet (1999) 2.59
Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J (1998) 2.56
Aquaporin-4 expression is increased in oedematous human brain tumours. J Neurol Neurosurg Psychiatry (2002) 2.42
The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology (1970) 2.19
The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis (2011) 2.19
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans. Development (1999) 2.08
A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitol Today (2000) 2.04
The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology (1970) 2.00
Mitotic mechanisms in Alzheimer's disease? J Cell Biol (1996) 2.00
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis (1995) 1.96
Treatment of malaria: some considerations and limitations of the current methods of assessment. Trans R Soc Trop Med Hyg (1990) 1.91
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol (1998) 1.80
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
Pioneer axon guidance by UNC-129, a C. elegans TGF-beta. Science (1998) 1.76
Artemisinins. Postgrad Med J (2005) 1.66
Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis (1995) 1.65
Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology (2001) 1.63
Operantly conditioned patterns on precentral unit activity and correlated responses in adjacent cells and contralateral muscles. J Neurophysiol (1973) 1.63
Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer (2002) 1.61
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res (1997) 1.60
Role of cerebral arterial blood in the regulation of brain temperature in the monkey. Am J Physiol (1968) 1.59
Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. J Biol Chem (1999) 1.59
Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human cerebral malaria. Lancet (1988) 1.55
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol (1997) 1.51
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine-sensitive falciparum malaria. Lancet (1989) 1.50
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
A model for the emergence of cooperation, interdependence, and structure in evolving networks. Proc Natl Acad Sci U S A (2001) 1.48
Cytoplasmic network arrays demonstrated by immunolocalization using antibodies to a high molecular weight protein present in cytoskeletal preparations from cultured cells. Exp Cell Res (1982) 1.47
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Targeting HSP90 for cancer therapy. Br J Cancer (2009) 1.44
Genes of Acanthamoeba: DNA, RNA and protein sequences (a review). J Protozool (1991) 1.44
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood (1998) 1.42
Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance. Cell Mol Life Sci (2006) 1.42
Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci U S A (2000) 1.41
Myelofibrosis secondary to SLE and its reversal on steroid therapy. Indian Pediatr (1995) 1.41
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia (2010) 1.41
Quinine disposition kinetics. Br J Clin Pharmacol (1983) 1.41
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res (1991) 1.40
Prospective assessment of two-stage testing for Clostridium difficile. J Hosp Infect (2010) 1.40
Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. Cancer Res (2001) 1.40
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol (1999) 1.37
Cytotoxic T-lymphocyte-associated antigen 4 antibody-induced colitis and its management with infliximab. Dig Dis Sci (2008) 1.37
Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J Exp Med (1999) 1.36
Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection. Cell Death Differ (2005) 1.35
Sensory and motor responses of precentral cortex cells during comparable passive and active joint movements. J Neurophysiol (1980) 1.32
The influence of the nasal mucosa and the carotid rete upon hypothalamic temperature in sheep. J Physiol (1968) 1.30
Assessment of pfmdr 1 gene copy number by tandem competitive polymerase chain reaction. Mol Biochem Parasitol (1997) 1.29
Oscillations and temporal signalling in cells. Phys Biol (2007) 1.28
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene. Proc Natl Acad Sci U S A (1992) 1.22
Inhibitors of carbohydrate processing: A new class of anticancer agents. Clin Cancer Res (1995) 1.22
Molecular mechanisms of brain tumor edema. Neuroscience (2004) 1.21
Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations. Int J Tuberc Lung Dis (2010) 1.21
Erythrocyte sequestration and anemia in severe falciparum malaria. Analysis of acute changes in venous hematocrit using a simple mathematical model. J Clin Invest (1990) 1.18
Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections. Eur J Clin Microbiol Infect Dis (2004) 1.17
Glucose and lactate kinetics in children with severe malaria. J Clin Endocrinol Metab (2000) 1.17
The plastid in Plasmodium falciparum asexual blood stages: a three-dimensional ultrastructural analysis. Protist (1999) 1.17
Metal ion homeostasis and intracellular parasitism. Mol Microbiol (1998) 1.17
A comparative study of the role of the cerebral arterial blood in the regulation of brain temperature in five mammals. Brain Res (1969) 1.17
Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites. Lancet (1992) 1.16
Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology (1999) 1.16
Brain cooling in endotherms in heat and exercise. Annu Rev Physiol (1982) 1.15
Factors associated with the catastrophic decline of a cloudforest frog fauna in Guatemala. Rev Biol Trop (2004) 1.14
Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J Exp Med (1972) 1.14
Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. Blood (2000) 1.13
Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat (1997) 1.11
Severe malaria: metabolic complications. Curr Mol Med (2006) 1.11
Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res (1987) 1.11
Diuretic and thermoregulatory responses to preoptic cooling in the monkey. Am J Physiol (1968) 1.09
Antimalarial multi-drug resistance in Asia: mechanisms and assessment. Curr Top Microbiol Immunol (2005) 1.08
Capping and stabilizing chronic intravascular cannulae. J Appl Physiol (1968) 1.08